The 4C results are out in droves, and it is worth while revisiting some of these 'falling knives' stocks as I have been warning you about.
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Column 7
Column 8
Column 9
0
Stock Code
Stock
Price
Share Base (mil)
Mcap (mil)
Annualised Revenues*
Mcap/Rev (times)
Gain/Loss% over 12 months
Drop from All Time High
1
YOJ[/B]
Yojee
$ 0.105
950.61
$ 99.81
$ 0.26
389.90
45.8%
-70.8%
2
EDE
Eden Concrete
$ 0.052
1,598.27
$ 83.11
$ 0.68
122.22
-76.4%
-85.6%
3
BRN
Brainchip
$ 0.155
1,079.43
$ 167.31
$ 1.65
101.44
-8.8%
-66.3%
4
BUD
Buddy Platform
$ 0.125
1,149.05
$ 143.63
$ 3.04
47.19
-41.9%
-70.2%
5
9SP
9 Spokes
$ 0.033
507.27
$ 16.74
$ 7.00
2.39
-75.6%
-84.3%
6
AXP
Airxpanders
$ 0.099
294.30
$ 29.14
$ 5.34
5.45
-85.9%
-93.4%
7
SAS
Sky & Space Global
$ 0.072
1,845.94
$ 132.91
$ -
n/a
-66.5%
-74.7%
8
Share Base on fully diluted basis (including Options, Performance shares, rights)
9
* Annualised Revenue computed as 4 x Latest 4C Quarterly Receipts or Annual Report or as declared in 4C
As you can see above, all the above stocks continue their downward trend , and latest results show they have not made any material traction to justify their lofty valuation as a potential growth stock.
They all share common similarities:
(1) Over hyped potential
(2) Large share base
(3) High Mcap/Revenue ratios - YOJ trades at 390 x revenues!
(4) Cashflow deficits
Be careful not to think they are cheap, as they are far from cheap- you can find stocks that have better validated business model with greater growth traction trading at just $20-30m mcap without high EV/Sales ratio.
10c or under 10c could look cheap relative to where it was trading before but you need to take into account their large share base and still lofty valuations.
